#GMOFinancialHD

On March 27, 2026, GMO Financial HD completed the acquisition of all shares of LASHIC Small Amount and Short-Term Insurance Co., Ltd., making it a subsidiary, and changed the trade name to GMO Small Amount and Short-Term Insurance Co., Ltd.

GMO Financial HD concluded a syndicated term loan agreement of 7.6 billion yen on March 27, 2026. The term is 3 years and unsecured. The impact on consolidated results is minor.

Operating revenue for February 2026 was 5,593 million yen, a 36.7% increase year-over-year. Securities and FX business generated 4,846 million yen, while the crypto asset business recorded revenue of 510 million yen.

The annual general meeting of shareholders will be held virtually only on March 19, 2026. The total number of authorized shares will be reduced from 187,500,000 shares to 150,000,000 shares due to a partial amendment of the Articles of Incorporation. Seven directors are scheduled to be appointed.

Operating revenue for January 2026 was 5,179 million yen, including 4,511 million yen from the Securities & FX business and 471 million yen from the Cryptocurrency business. Year-over-year comparison is unknown.

For the fiscal year ending December 2025, operating revenue was 495.18 billion yen (7.0% decrease YoY), operating income was 15.866 billion yen (77.8% increase YoY), and net income attributable to owners of parent was 10.448 billion yen (120.2% increase YoY), marking a record high.

GMO Financial HD has introduced a DOE (consolidated dividend on equity) floor indicator of 10% and announced an annual dividend forecast of 42.08 yen for the fiscal year ending December 2026.

The dividend per share for the 4th quarter of the fiscal year ending December 2025 was decided at 8 yen 48 sen, with a total dividend amount of 1,000 million yen, effective March 23, 2026.

Change of representative executive officer effective March 19, 2026. Mr. Tomitaka Ishimura steps down, and Mr. Hideyuki Takashima continues as Chairman and CEO.